Lv11
30 积分 2025-11-13 加入
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
2小时前
已完结
Genetic variants associated with expression of TCF19 contribute to the risk of head and neck cancer in Chinese population
3天前
已完结
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 Inactivation
5个月前
已完结
Computational Identification of Preneoplastic Cells Displaying High Stemness and Risk of Cancer Progression
6个月前
已完结
皖公网安备34019202002308
